(EMAILWIRE.COM, March 03, 2010 ) Dallas, Tx – Cell Therapeutics, Inc. (NASDAQ:CTIC) climbed up 4.85% to $0.712. The stock has a 52-week range of $0.05-$2.23. Cell Therapeutics, Inc. (Cell Therapeutics) develops, acquires and commercializes treatments for cancer.…
Tagged as: bankruptcy, chronic hepatitis c, Equity, financial news, harvard medical school, human genome sciences, stock market, stocks
by India-News on 2009/08/12
in news
by India-News on 2009/08/11
in news
Knopp Neurosciences Inc. said the results of a Phase 2 safety and tolerability study of KNS-760704 in amyotrophic lateral sclerosis (ALS) will be presented at the 20th International Symposium on ALS/MND in Berlin on December 9, 2009.
The Phase 2…
Tagged as: harvard medical school